Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking

  08 January 2020

Seattle-based startup Phase Genomics announced Tuesday it has received a two-year, $1.5 million grant from the National Institutes of Health to support the development of a rapid antimicrobial resistance tracking kit based on the firm’s proprietary high-throughput chromatin conformation, or Hi-C, proximity ligation technology.

The Phase II Small Business Innovation Research funds were awarded by the National Institute of Allergy and Infectious Diseases. The funding will support the development of a low-cost platform to detect antimicrobial resistance elements in microbial communities without the need for bacterial culture.

Further reading: Genome Web
Author(s): staff reporter
Smart Innovations  


Unrestricted financial support by:


Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!